2Charteris DG, Downie J,Aylward GW, et al. Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy [ J ]. Graefe's Arch Clin Exp Ophthalmol,2007,245 ( 1 ) : 93 - 100.
3Kuo CN, Chen CY, Lai CH, et al. Cell cycle regulation by bevacizumab in ARPE-19 human retinal pigment epithelial cells[J], Mol Med Rep, 2012.6 (4) :701-704. doi:10. 3892/mmr. 2012. 986.
4Leiderman YI, Miller JW. Proliferative vitreoretlnopathy: pathobiology and therapeutic targets [ J ]. Semin Ophthalmol, 2009,24 ( 2 ) : 62 - 69. doi : 10. 1080/08820530902800082.
5Gartel AL. The conflicting roles of the cdk inhibitor p21 ( CIP1/WAF1 ) in apoptosis [ J 1. Leuk Res, 2005,29 ( 11 ) : 1237 - 1238.
6Mufioz-Esptn D, Cafiamero M, Maraver A, et al. Programmed cell senescence during mammalian embryonic development[ J]. Ce11,2013, 155(5) : 1104-1118. doi:10. 1016/j. ce11.2013.10.019.
7Bishop A J, Kosaras B, Hollander MC ,et al. p21 controls patterning but not homologous recombination in RPE development ~ J ]. DNA Repair (Amst) ,2006,5 (1) : 111- 120. doi: 10. 1016/j. dnarep. 2005. 08. 015.
8Takamura Y. Increased expression of p21 ( WAF-1/CIP-1 ) in the lens epithelium of rat sugar cataract [ J]. Exp Eye Res, 2002,74 (2) : 245-254. doi : 10. 1006/exer. 2001.1120.
9Vernon AE, Devine C, Philpott A. The cdk inhibitor p27Xicl is required for differentiation of primary neurones in Xenopus [ J ]. Development,2003,130 ( 1 ) : 85-92.
10Sakamoto K, Ohki K, Saito M, et al. Small molecule cyclin-dependent kinase inhibitors protect against neuronal celX death in the ischemic- reperfused rat retina [ J ]. J Ocul Pharmacol Ther,2011,27 (5) : 419-425. doi: 10. 1089/jop. 2010. 0141.
